| 2018 | A prognostic scoring system for patients with multiple myeloma classified as stage II with the Revised International Staging System | 김진석 | Article |
| 2018 | Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150) | 김진석 | Article |
| 2018 | HBsAg-Negative, Anti-HBc-Negative Patients Still Have a Risk of Hepatitis B Virus-Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma
| 김도영, 김수정, 김진석, 민유홍, 박현성, 송재우, 장지은, 정준원, 정해림 | Article |
| 2017 | The prognostic role of CD68 and FoxP3 expression in patients with primary central nervous system lymphoma | 김세훈, 김수정, 김유리, 김윤덕, 김진석, 민유홍, 서창옥, 양우익, 이정연, 장종희, 장지은, 정준원 | Article |
| 2017 | Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study. | 김진석 | Article |
| 2017 | Prognostic significance of interventricular septal thickness in patients with AL amyloidosis | 김수정, 김유리, 김진석, 민유홍, 심지영, 양우익, 장지은, 정준원, 정해림, 하종원, 홍그루 | Article |
| 2017 | Long-Term Follow-Up of Patients After Autologous Bone Marrow Cell Infusion for Decompensated Liver Cirrhosis
| 김도영, 김수정, 김유리, 김자경, 김진석, 김현옥, 박미숙, 박영년, 안상훈, 이관식, 이정일, 정용은, 한광협 | Article |
| 2017 | 내과 전문의 시험제도의 발전방향
| 김진석, 하종원 | Article |
| 2017 | Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores | 김수정, 김유리, 김진석 | Article |
| 2017 | Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation
| 김수정, 김진석, 김현주, 민유홍, 변화경, 서창옥, 유철주, 윤홍인, 이원희, 정준원, 조재호 | Article |
| 2017 | Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of "RISK" Study | 김진석, 정준원 | Article |
| 2017 | Clinical characteristics and treatment outcomes of isolated myeloid sarcoma without bone marrow involvement: a single-institution experience
| 김수정, 김윤덕, 김진석, 민유홍, 장지은, 정준원, 정해림 | Article |
| 2017 | Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort
| 김진석 | Article |
| 2017 | Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphoma
| 김세훈, 김수정, 김유리, 김진석, 민유홍, 서창옥, 양우익, 장종희, 장지은, 정준원 | Article |
| 2017 | Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial
| 김진석 | Article |
| 2017 | The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160)
| 김진석 | Article |
| 2017 | Pretreatment Epstein-Barr virus DNA in whole blood is a prognostic marker in peripheral T-cell lymphoma
| 김수정, 김유리, 김윤덕, 김진석, 민유홍, 양우익, 장지은, 정준원, 정해림 | Article |
| 2017 | Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma | 김수정, 김윤덕, 김진석, 민유홍, 이정연, 장지은, 정준원, 정해림 | Article |
| 2017 | Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
| 김진석 | Article |
| 2017 | Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 compared with rituximab in patients with previously untreated advanced-stage follicular lymphoma: a randomised, double-blind, parallel-group, non-inferiority phase 3 trial. | 김진석 | Article |
| 2017 | Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells. | 김진석, 민유홍, 이정연, 장지은, 정준원 | Article |
| 2017 | Decitabine as a First-Line Treatment for Older Adults Newly Diagnosed with Acute Myeloid Leukemia
| 김수정, 김윤덕, 김진석, 민유홍, 박현성, 이정연, 장지은, 정준원 | Article |
| 2017 | Hematopoietic stem cell mobilization: current status and future perspective
| 김진석 | Article |
| 2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma
| 김진석 | Article |
| 2017 | Comprehensive Evaluation of the Revised International Staging System in Multiple Myeloma Patients Treated with Novel Agents as a Primary Therapy | 김진석 | Article |
| 2017 | AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells | 김진석, 민유홍, 이정연, 장지은, 정준원 | Article |
| 2016 | Daratumumab 투여를 받은 다발성 골수종 환자에서 비예기항체 동정검사상 범응집 소견을 보인 1예
| 김대원, 김진석, 김현옥, 나현진, 이은경, 조주영 | Article |
| 2016 | Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study
| 김진석 | Article |
| 2016 | Distinct subgroups of paroxysmal nocturnal hemoglobinuria (PNH) with cytopenia: results from South Korean National PNH Registry | 김진석 | Article |
| 2016 | High pre-transplant serum ferritin and busulfan-thiotepa conditioning regimen as risk factors for hepatic sinusoidal obstructive syndrome after autologous stem cell transplantation in patients with malignant lymphoma. | 김수정, 김윤덕, 김진석, 민유홍, 양우익, 이정연, 장지은, 정준원 | Article |
| 2016 | Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens
| 김수정, 김윤덕, 김진석, 민유홍, 송재우, 이정연, 장지은, 정준원, 한상훈 | Article |
| 2016 | A new prognostic model using absolute lymphocyte count in patients with primary central nervous system lymphoma | 김수정, 김유리, 김윤덕, 김진석, 민유홍, 박현성, 이정연, 장지은, 정준원, 정해림 | Article |
| 2016 | Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study. | 김진석 | Article |
| 2016 | Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry.
| 김수정, 김윤덕, 김진석, 민유홍, 송재우, 이정연, 장지은, 정준원 | Article |
| 2016 | Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF. | 김수정, 김진석, 장지은, 정준원 | Article |
| 2016 | Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea
| 김진석, 신재일 | Article |
| 2016 | Epstein-Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin | 김진석 | Article |
| 2016 | Prognostic value of the inverse platelet to lymphocyte ratio (iPLR) in patients with multiple myeloma who were treated up front with a novel agent-containing regimen | 김진석 | Article |
| 2016 | A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial | 김진석 | Article |
| 2016 | Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29) | 김진석 | Article |
| 2016 | A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomas | 김진석 | Article |
| 2016 | Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party
| 김진석 | Article |
| 2016 | Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia | 김수정, 김진석 | Article |
| 2016 | A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis | 김진석 | Article |
| 2016 | Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen
| 김수정, 김진석, 정준원 | Article |
| 2016 | The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma.
| 김진석, 서창옥, 양우익, 조재호 | Article |
| 2016 | The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase | 김수정, 김유리, 김진석, 민유홍, 양우익, 정준원 | Article |
| 2016 | Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study
| 김진석 | Article |
| 2016 | The role of upfront autologous stem cell transplantation in high-risk younger patients with primary central nervous system lymphoma | 김세훈, 김수정, 김유리, 김윤덕, 김진석, 민유홍, 박현성, 서창옥, 양우익, 이정연, 장종희, 장지은, 정준원, 정해림 | Article |
| 2015 | Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia | 김수정, 김유리, 김윤덕, 김진석, 민유홍, 장지은, 정준원 | Article |
http://orcid.org/0000-0001-8986-8436
(Yonsei Health Research Network)
(55032033600)
